The TREOCAPA trial was a multicenter, phase III study involving 14 European countries. The study investigated the preventive use of paracetamol, in preterm infants (23–26 weeks of gestation), evaluating its impact on the closure of patent ductus arteriosus as well as on common complications associated with preterm birth. conect4children worked in close collaboration with the sponsor INSERM, ECRIN, and GFCNI, to support the study’s execution. In Portugal, the three participating sites were also supported by STAND4Kids...Continue Reading

Our Highlights this month are dedicated to our activities from July to October. This edition showcases our main activities aimed at promoting high quality paediatric clinical trials. Download [HERE].Continue Reading

Collaboration is everything! A heartfelt thank you to Boehringer Ingelheim for inviting us to join and support the European Investigators’ Meeting. STAND4Kids is proud to be part of the launch of this exciting paediatric chronic kidney disease (CKD) study. With our team engaged, we are committed to helping Boehringer Ingelheim move swiftly through study enrollment...Continue Reading